Literature DB >> 29510146

Feasibility and safety of microforceps biopsy in the diagnosis of pancreatic cysts.

Omer Basar1, Osman Yuksel2, Dennis J Yang3, Jason Samarasena4, David Forcione1, Christopher J DiMaio5, Mihir S Wagh6, Kenneth Chang4, Brenna Casey1, Carlos Fernandez-Del Castillo7, Martha B Pitman8, William R Brugge1.   

Abstract

BACKGROUND AND AIMS: The tissue acquisition and diagnostic yield of cyst fluid cytology is low-to-moderate and rarely provides a specific diagnosis. The aim of this study was to compare the tissue acquisition and diagnostic tissue yield of microforceps biopsy (MFB) with cyst fluid cytology.
METHODS: In this multicenter study, data of 42 patients who had cysts both aspirated by EUS-guided FNA (EUS-FNA) and biopsy specimens were then obtained with an MFB device, were collected. Cytology analysis of cyst fluid and histologic analysis of biopsy specimens were done. Acquisition yield was defined as percentage of patients with tissue present in the aspirate or biopsy. Diagnostic tissue yield was evaluated at 3 levels: the ability of differentiation between mucinous and/or nonmucinous cysts, detection of high risk for malignancy, and specific cyst type diagnosis.
RESULTS: The mean patient age was 69 years. Sixteen pancreatic cysts (38.1%) were located in the head, 17 (40.5%) in the body, and 9 (21.4%) in the tail. The mean cyst size was 28.2 mm (12-60 mm); 25 of 42 (60%) were septated. The EUS-FNA tissue (fluid) acquisition yield was 88.1% (37/42). The MFB tissue acquisition yield was 90.4% (38/42). The diagnostic cytology yield to differentiate between mucinous and/or nonmucinous cysts was 47.6% (20/42), and the MFB histologic yield to differentiate between mucinous and/or nonmucinous cysts was 61.9% (26/42) (P = .188). The percentage of cysts at high risk for malignancy by cytology was 54.7% (23/42), and MFB was 71.5% (30/42) (P = .113). However, the ability of MFB to provide a specific cyst type diagnosis was 35.7% (15/42), and that for cytology was 4.8% (2/42) (P = .001). Surgical histology was concordant with that of MFB in 6 of 7 patients (85%), and with that of cytology in 1 of 7 patients (15%).
CONCLUSION: The cyst tissue acquisition yield for MFBs was 90%. Although cytology of cyst fluid and MFB were comparable in distinguishing mucinous and nonmucinous cysts and detecting cysts at high risk for malignancy, MFB was far superior to cytology for providing a specific cyst diagnosis. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29510146     DOI: 10.1016/j.gie.2018.02.039

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  13 in total

Review 1.  Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: recommendations for Standardized Imaging and Reporting from the Society of Abdominal Radiology IPMN disease focused panel.

Authors:  Elizabeth M Hecht; Gaurav Khatri; Desiree Morgan; Stella Kang; Priya R Bhosale; Isaac R Francis; Namita S Gandhi; David M Hough; Chenchan Huang; Lyndon Luk; Alec Megibow; Justin M Ream; Dushyant Sahani; Vahid Yaghmai; Atif Zaheer; Ravi Kaza
Journal:  Abdom Radiol (NY)       Date:  2020-11-13

2.  Diagnostic value of SpyGlass for pancreatic cystic lesions: comparison of EUS-guided fine-needle aspiration and EUS-guided fine-needle aspiration combined with SpyGlass.

Authors:  Chen Du; Ningli Chai; Enqiang Linghu; Huikai Li; Xiuxue Feng; Xiangdong Wang; Ping Tang
Journal:  Surg Endosc       Date:  2021-03-01       Impact factor: 4.584

Review 3.  Endosonographic diagnosis of advanced neoplasia in intraductal papillary mucinous neoplasms.

Authors:  Andrew Eiterman; Ali Lahooti; Somashekar G Krishna
Journal:  World J Gastroenterol       Date:  2020-06-21       Impact factor: 5.742

4.  Improving the yield of EUS-guided histology.

Authors:  Luca Barresi; Matteo Tacelli; Ilaria Tarantino; Fabio Cipolletta; Antonino Granata; Mario Traina
Journal:  Endosc Ultrasound       Date:  2018 Sep-Oct       Impact factor: 5.628

5.  Mucinous cystic neoplasm diagnosed by EUS-guided microforceps biopsy.

Authors:  Jordan Orr; Robert Lockwood; Safia Salaria; Anthony Gamboa; Patrick Yachimski
Journal:  Endosc Int Open       Date:  2018-11-07

Review 6.  Pancreatic Cysts: Diagnostic Role of EUS-Guided Microforceps Biopsy and Confocal Laser Endomicroscopy.

Authors:  Darina Kohoutova; Sameer Zar; Rudolf Repak; Panagiotis Vlavianos; Jan Bures
Journal:  Gastroenterol Res Pract       Date:  2019-09-12       Impact factor: 2.260

7.  The use of EUS-microforceps biopsies to evaluate patients with pancreatic cystic lesions.

Authors:  Arcelia Guerson; Sammy Ho
Journal:  Endosc Ultrasound       Date:  2020 Jul-Aug       Impact factor: 5.628

Review 8.  EUS-guided through-the-needle microbiopsy of pancreatic cysts: Technical aspects (with video).

Authors:  Bojan Kovacevic; Evangelos Kalaitzakis; Pia Klausen; Lene Brink; Hazem Hassan; John G Karstensen; Peter Vilmann
Journal:  Endosc Ultrasound       Date:  2020 Jul-Aug       Impact factor: 5.628

9.  Microforceps in the Diagnosis of Pancreatic Bronchogenic Cyst Under Endoscopic Ultrasound Guidance.

Authors:  Abdul Kouanda; Sarah Umetsu; Sun-Chuan Dai
Journal:  ACG Case Rep J       Date:  2020-03-19

10.  Endoscopic ultrasound-through-the-needle biopsy in pancreatic cystic lesions: A large single center experience.

Authors:  Rintaro Hashimoto; John G Lee; Kenneth J Chang; Nabil El Hage Chehade; Jason B Samarasena
Journal:  World J Gastrointest Endosc       Date:  2019-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.